NCT02964078 2026-02-10Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed27 enrolled 10 charts
NCT02955069 2021-04-12Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)NovartisPhase 2 Completed116 enrolled 24 charts